Jakub Rohlena
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 24
- Cancer-related molecular mechanisms research 3
- Molecular Biology top 5%
- Mitochondrial Function and Pathology 21
- ATP Synthase and ATPases Research 14
- RNA modifications and cancer 4
- Biochemical and Molecular Research 3
- Aging top 10%
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders 5
- Immunology top 10%
-
- Autophagy in Disease and Therapy 4
- Co-authors
- Jiřı́ NeužilLan‐Feng DongStephen J. RalphHans PannekoekJaroslav TruksaRob J. DekkerAnton J.G. HorrevoetsAyenachew Bezawork‐Geleta
- Journals
- Journal of Biological Chemistry (2 papers)Circulation (1 paper)Nature Communications (2 papers)
- Partner nations
- CzechiaAustraliaNetherlands
In The Last Decade
Jakub Rohlena
50 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Cancer Research 644
- Molecular Biology 1.6k
- Aging 28
- Clinical Biochemistry 86
- Immunology 232
Countries citing papers authored by Jakub Rohlena
This map shows the geographic impact of Jakub Rohlena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakub Rohlena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakub Rohlena more than expected).
Fields of papers citing papers by Jakub Rohlena
This network shows the impact of papers produced by Jakub Rohlena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakub Rohlena. The network helps show where Jakub Rohlena may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jakub Rohlena, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 6 | |
| 4 | 2022 | 11 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 10 | |
| 7 | 2021 | 27 | |
| 8 | 2021 | 37 | |
| 9 | 2020 | 53 | |
| 10 | 2017 | 201 | |
| 11 | 2016 | 26 | |
| 12 | 2015 | 51 | |
| 13 | 2015 | 2 | |
| 14 | 2013 | 7 | |
| 15 | 2012 | 91 | |
| 16 | 2012 | 194 | |
| 17 | 2011 | 83 | |
| 18 | 2006 | 29 | |
| 19 | 2005 | 289 | |
| 20 | 2003 | 22 |
About Jakub Rohlena
Jakub Rohlena is a scholar working on Cancer Research, Clinical Biochemistry and Molecular Biology, having authored 52 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (24 papers), Mitochondrial Function and Pathology (21 papers), ATP Synthase and ATPases Research (14 papers), Metabolism and Genetic Disorders (5 papers), Autophagy in Disease and Therapy (4 papers), RNA modifications and cancer (4 papers), Biochemical and Molecular Research (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (644 citations), Molecular Biology (1.6k citations) and Aging (28 citations). Jakub Rohlena has collaborated with scholars based in Czechia, Australia and Netherlands. Frequent co-authors include Jiřı́ Neužil, Lan‐Feng Dong, Stephen J. Ralph, Hans Pannekoek, Jaroslav Truksa, Rob J. Dekker, Anton J.G. Horrevoets, Ayenachew Bezawork‐Geleta, Karel Pacák and Theo J.C. van Berkel. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.